European Commission Approves Astellas’ PADCEV with KEYTRUDA for Advanced Urothelial Cancer
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura) has announced that the European Commission has granted Marketing Authorization for PADCEV™ (enfortumab vedotin, an antibody-drug conjugate [ADC]) in combination…
Moderna Unveils Nationwide Campaign to Boost COVID-19 Vaccination Rates
Moderna, Inc. (NASDAQ) has announced the launch of its new awareness initiative, “Do It For You & Them,” aimed at boosting COVID-19 vaccination rates across the United States. This campaign…
Marketing and Future Prospects for the Secondary Hyperparathyroidism Drug ‘OXAROL for Injection’ in Japan
Chugai Pharmaceutical Co., Ltd. [Head Office: Tokyo, President and CEO: Osamu Okuda] and LTL Pharma Co., Ltd. [Head Office: Tokyo, President and Representative Director: Tetsuo Ito] have announced an agreement…
Japan Approves Alecensa for Adjuvant Treatment of ALK-Positive Early-Stage Non-Small Cell Lung Cancer
Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) has announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Alecensa® (generic name: alectinib) for the additional indication of “adjuvant therapy…
Merck Begins Phase III Study with First Patient Dosed for Oral Cladribine in gMG
Merck, a leading science and technology company, has announced that the first patient has been dosed in the Phase III MyClad trial (NCT06463587). This trial aims to evaluate the efficacy…
EU Approves Expanded Use of GSK’s Arexvy RSV Vaccine for At-Risk Adults Aged 50-59
GSK plc (LSE/NYSE: GSK) has announced that the European Commission has authorized Arexvy, a recombinant adjuvanted respiratory syncytial virus (RSV) vaccine, for active immunization to prevent lower respiratory tract disease…
Get Your Updated Flu and COVID-19 Vaccinations Now at CVS Pharmacy and MinuteClinic
CVS Pharmacy® (NYSE: CVS) has announced that the updated COVID-19 vaccines for the 2024-2025 season, along with flu vaccines, are now available at CVS Pharmacy and MinuteClinic® locations nationwide. Walk-ins…
Roche’s PiaSky Receives EU Approval as the First Monthly Subcutaneous Treatment for PNH Patients
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved PiaSky® (crovalimab), a novel monoclonal antibody designed to inhibit the complement protein C5, for the treatment…
Hinge Health and Midi Health Collaborate to Offer Comprehensive Menopause Care
Hinge Health and Midi Health have announced a partnership aimed at addressing the significant healthcare gap for women undergoing menopause. This collaboration merges Hinge Health’s expertise in movement-based support for…
MedImpact Broadens Access to Two Humira Biosimilars for New Patients
MedImpact Healthcare Systems, Inc., the largest independent provider of health solutions, technology, and pharmacy benefit services in the U.S., announced today the expansion of access to Humira biosimilars—Simlandi and adalimumab-adaz—for…
Avanzati Bioscience Secures EU Approval for Orphan Drug AKANTIOR
Avanzanite Bioscience BV, a specialty pharmaceutical company in the development stage, has announced that the European Commission (EC) has granted marketing authorization for AKANTIOR® (polihexanide), a treatment for acanthamoeba keratitis…
Correction OMNY Health Expands GLP-1 Patient Network to Over 600,000 for Enhanced Clinical Research
OMNY Health, a leader in creating compliant cross-industry data partnerships, has announced the launch of its Glucagon-Like Peptide-1 (GLP-1) data network, reinforcing its mission to democratize healthcare data. This new…